Company Profile

ITT Inc., together with its subsidiaries, manufactures and sells engineered critical components and customized technology solutions for the transportation, industrial, and energy markets. The company operates three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shock absorbers, energy absorption components, and damping technologies primarily for the transportation industry, including passenger cars, trucks, light and heavy-duty commercial and military vehicles, buses, and trains. This segment sells its products under the ITT Friction Technologies, KONI, Axtone, and Novitek brand names. The Industrial Process segment provides industrial pumps, valves, plant optimization, and remote monitoring systems and services; and aftermarket solutions, such as replacement parts and services. It serves various customers in the energy, chemical and petrochemical, pharmaceutical, general industrial, marine, mining, pulp and paper, food and beverage, power generation, and biopharmaceutical industries. This segment sells its products under the Goulds Pumps, Bornemann, Engineered Valves, Hamworthy Pumps, PRO Services, C'treat, Svanehøj, Rheinhütte Pumpen, and Habonim brand names. The Connect & Control Technologies segment offers engineered connectors, cable assemblies, and specialized products for critical applications supporting various markets, including aerospace and defence, industrial, transportation, medical, and energy under the Cannon, VEAM, BIW Connector Systems, CIA&D, Compulink, Aerospace Controls, Enidine, Compact Automation, Charles E. Gillman, Turn-Act, Neo-Dyn, TopFlite Components, Conoflow, VIDAR, kSARIA, and Micro-Mode brand names. It operates in North America, Europe, Asia, the Middle East, Africa, and South America. The company was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Latest News

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026

Business Wire • 07/23/2026

Honeywell International Inc. (HON) Beats Q2 Earnings and Revenue Estimates

Zacks • 07/23/2026

Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study

Business Wire • 07/22/2026

CIB vs. ITT: Which Stock Is the Better Value Option?

Zacks • 07/20/2026

ITT to Release Second Quarter 2026 Results on Thursday, August 6

Business Wire • 07/16/2026